NASDAQ:VTGN

Vistagen Therapeutics Stock Predictions

etoro logo Buy VTGN
*Your capital is at risk
$0.560
-0.0199 (-3.43%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VTGN Prediction Chart

VTGN Predictions History

Latest community submissions for VTGN.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 21, 2023 $0.202 -96.63% $0.179 X 87.02% 0
AlexVel AlexVel Pro
Feb 14, 2023 $0.219 -96.83% $0.228 V 96.21% 1
JS JS Pro
Feb 14, 2023 $0.239 -96.54% $0.228 X 94.99% 0
Feb 14, 2023 $0.211 -96.94% $0.228 V 92.92% 1
Feb 14, 2023 $0.240 -96.52% $0.228 X 94.65% 0
AlexVel AlexVel Pro
Feb 8, 2023 $0.245 -96.86% $0.186 V 68.23% 1
Feb 8, 2023 $0.275 -96.48% $0.186 X 52.18% 0
Feb 8, 2023 $0.252 -96.77% $0.186 V 64.54% 1
JS JS Pro
Feb 8, 2023 $0.266 -96.59% $0.186 X 56.99% 0
JS JS Pro
Feb 7, 2023 $0.239 -96.81% $0.261 V 91.64% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VTGN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VISTAGEN THERAPEUTICS INC
VistaGen Therapeutics
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE